Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization

Area of Science:

• Regenerative Medicine
• Vascular Biology
• Cell Therapy

Background:

• Endothelial precursor cells (EPCs) are crucial for neovascularization.
• Adult peripheral blood is a known source of EPCs.
• Umbilical cord blood (UCB) is a potential alternative source for hematopoietic progenitors.

Purpose of the Study:

• To investigate the isolation and characterization of EPCs from UCB.
• To evaluate the potential of UCB-derived EPCs in modulating postnatal neovascularization in vivo.

Main Methods:

• Culture of UCB mononuclear cells (MNCs) to identify EPCs.
• Characterization of EPCs using immunofluorescence and cell surface markers (CD34, KDR, VE-cadherin, CD31, von Willebrand factor, CD45).
• In vivo transplantation of EPCs into ischemic hindlimb models in immunodeficient rats.

Main Results:

• UCB MNCs efficiently generated EPCs, including attaching (AT) cells and cord-like structures, predominantly from CD34+ cells.
• UCB-derived AT cells exhibited multiple endothelial phenotypes and incorporated acetylated-LDL.
• Transplanted UCB-derived EPCs survived, integrated into capillary networks, and significantly enhanced neovascularization and blood flow in ischemic tissues.

Conclusions:

• UCB is a valuable and efficient source of EPCs.
• Transplantation of UCB-derived EPCs is a promising strategy for promoting neovascularization and treating ischemic conditions.